Michal Mego

23PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 02, 2026
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

|Dec 04, 2025
Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy.

Michal Mego, Barbora Vlkova, Katarina Kalavska

|Jan 10, 2025
The effects of regular exercise on cognitive and cardiometabolic health in testicular cancer survivors subjected to platinum-based chemotherapy.

Ali Amiri, Lucia Slobodová, Radka Klepochová

|Jan 08, 2025
Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors.

Sona Ciernikova, Aneta Sevcikova, Maria Novisedlakova

|Jan 23, 2024
Microbiome in Cancer Development and Treatment.

Sona Ciernikova, Aneta Sevcikova, Beata Mladosievicova

|Dec 23, 2023
Exploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis.

Aneta Sevcikova, Beata Mladosievicova, Michal Mego

Pageof 4

Frequent Collaborators

7 joint publications

Sona Ciernikova

7 joint publications

Michal Chovanec

3 joint publications

Martin Janicko

3 joint publications

Lubomir Skladany